They showed that SOCS3 expression is downregulated in HCC patients, as well as in cells transfected with miR-221, and that in vitro miR-221 inhibition or SOCS3 overexpression inhibits tumor growth. The gene discussed is SOCS3; the disease is hepatocellular carcinoma.